HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Manabu Hagaya Selected Research

1- (3,5,5,8,8- pentamethyl- 5,6,7,8- tetrahydro- 2- naphthyl)- 1H- benzotriazole- 5- carboxylic acid

3/2013Mechanism of retinoid X receptor partial agonistic action of 1-(3,5,5,8,8-pentamethyl-5,6,7,8-tetrahydro-2-naphthyl)-1H-benzotriazole-5-carboxylic acid and structural development to increase potency.
5/2012RXR Partial Agonist CBt-PMN Exerts Therapeutic Effects on Type 2 Diabetes without the Side Effects of RXR Full Agonists.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Manabu Hagaya Research Topics

Disease

2Type 2 Diabetes Mellitus (MODY)
03/2013 - 05/2012
1Insulin Resistance
05/2012

Drug/Important Bio-Agent (IBA)

21- (3,5,5,8,8- pentamethyl- 5,6,7,8- tetrahydro- 2- naphthyl)- 1H- benzotriazole- 5- carboxylic acidIBA
03/2013 - 05/2012
2Retinoid X Receptors (Retinoid X Receptor)IBA
03/2013 - 05/2012
1Therapeutic UsesIBA
05/2012